Tag: Christopher Porter
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
